2023

133.   Bubak, A.N., Merle, L, Niemeyer, C.S., Baxter, B.D., Polese, A.G., Ramakrishnan, V., Gomez, J., Madrigal, L., Villegas-Lanau, A., Lopera, F., Macklin, W., Frietze, S., Nagel, M.A., Restrepo, D.: Signatures for viral infection and inflammation in the proximal olfactory system in familial Alzheimer’s disease. Neurobiol. Aging 123:75-82, 2023.

132. Bubak, A.N., Coughlan, C., Posey, J., Saviola, A.J., Niemeyer,C.S., Lewis, S.W.R., Bustos Lopez, S., Solano, A., Tyring, S.K., Delaney, C., Neeves, K.B., Mahalingam, R., Hansen, K.C., Nagel, M.A.: Zoster-associated prothrombotic plasma exosomes and increased stroke risk. J. Infect. Dis. 227:993-1001, 2023.

2022

131.   Mahalingam, R., Feia, B., Coleman, C., Anupindi, K., Saravanan, P., Luthens, A., Bustilios, A., Das, A., de Haro, E., Doyle-Meyers, L., Looper, J., Bubak, A.N., Niemeyer, C.S., Palmer, B., Nagel, M.A., Traina-Dorge, V.: Simian varicella virus pathogenesis in skin during varicella and zoster. Viruses 14:1167; doi: 10.3390/v14061167, 2022.

130.   Sarkar, L., Oko, L., Gupta, S., Bubak, A.N., Das, B., Gupta, P., Safiriyu, A.A., Singhal, C., Neogi, U., Bloom, D., Banerjee, A., Mahalingam, R., Cohrs, R.J., Koval, M., Shindler, K.S., Pal, D., Nagel, M., Das Sharma, J.: Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replication. Virology 569:13-28, 2022.

 129.   Niemeyer, C.S., Mescher, T., Bubak, A.N., Medina, E.M., Hassell, J.E. Jr., Nagel, M.A.: VZV infection of primary human adrenal cortical cells produces a proinflammatory environment without cell death. Viruses 14:674; doi: 10.3390/v14040674, 2022.

128.   Bubak, A.N., Como, C.N., Hassell, J.E. Jr., Mescher, T., Frietze, S.E., Niemeyer, C.S., Cohrs, R.J., Nagel, M.A.: Targeted RNA sequencing of VZV-infected brain vascular adventitial fibroblasts indicates that amyloid may be involved in VZV vasculopathy. Neurol. Neuroimmunol. Neuroinflamm. 9:e1103; doi: 10.1212/NXI.0000000000001103, 2022.

2021

127.   Bubak, A.N., Mescher, T., Mariani, M., Frietze, S.E., Hassell, J.E. Jr., Niemeyer, C.S., Como, C.N., Burnet, A.M., Subramnian, P.S., Cohrs, R.J., Mahalingam, R., Nagel, M.A.: Targeted RNA sequencing of formalin-fixed, paraffin-embedded temporal arteries from giant cell arteritis cases reveals viral signatures. Neurol. Neuroimmunol. Neuroinflamm. 8:e1078; doi: 10.1212/NXI.0000000000001078, 2021.

126.   Niemeyer, C.S., Mescher, T., Griggs, R., Orlicky, D.J., Wilkerson, G.K., Bubak, A.N., Hassell, J.E. Jr., Feia, B., Mahalingam, R., Traina-Dorge, V., Nagel, M.A.: Histopathological analysis of adrenal glands after simian varicella virus infection. Viruses 13:1245; doi: 10.3390/v13071245, 2021.

125.    Bertamino, M., Signa, S., Veneruso, M., Prato, G., Caorsi, R., Losurdo, G., Teutonico, F., Esposito, S., Formica, F., Tovaglieri, N., Nagel, M.A., Amico, G., Zanetti, A., Tortora, D., Rossi, A., Moretti, P., Gattorno, M., Ravelli, A., Severino, M., in behalf of Gaslini Stroke Study Group. Expanding the clinical and neuroimaging features or post-varicella arteriopathy of childhood. J. Neurol. 268:4846-4865, 2021.

124.   Baxter, B.D., Larson, E.D., Merle, L., Feinstein, P., Polese, A.G., Bubak, A.N., Niemeyer, C.S., Hassell, J. Jr., Shepherd, D., Ramakrishnan, V.R., Nagel, M.A., Restrepo, D.: Transcriptional profiling reveals potential involvement of microvillous TRPM5-expressing cells in viral infection of the olfactory epithelium. BMC Genomics 22;224, 2021.

123.   Mescher, T., Boyer, P.J., Bubak, A.N., Hassell, J.E. Jr., Nagel, M.A.: Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy. J. Neurol. Sci. 422:117315, 2021.

122.  Bertamino, M., Signa, S., Vagelli, G., Caorsi, R., Zanetti, A., Volpi, S., Losurdo, G., Amico, G., Dodi, I., Prato, G., Ronchetti, A.B., Di Rocco, M., Nagel, M., Severino, M.: An atypical case of post-varicella stroke in a child presenting with hemichorea followed by late-onset inflammatory focal cerebral arteriopathy. Quant. Imaging Med. Surg. 11:463-471, 2021.

121.   Bubak, A.N., Beseler, C., Como, C.N., Coughlan, C.M., Johnson, N.R., Hassell, J.E. Jr., Burnet, A.M., Mescher, T., Schmid, D.S., Coleman, C., Mahalingam, R., Cohrs, R.J., Boyd, T.D., Potter, H., Shilleh, A.H., Russ, H.A., Nagel, M.A.: Amylin, Aβ42, and amyloid in varicella zoster virus vasculopathy cerebrospinal fluid and infected vascular cells. J. Infect. Dis. 223:1284-1294, 2021.

2020

120.   Gilden, D., Cohrs, R.J., Jones, D., Nagel M.A.: Varicella zoster virus infection. In: Clinical Neurovirology, 2nd Edition (A. Nath, J.R. Berger, eds.), CRC Press, Taylor & Francis Group, Boca Raton, FL, Chap. 6:58-71, 2020.

119.   Bubak, A.N., Traina-Dorge, V., Como, C.N., Feia, B., Pearce, C.M., Doyle-Meyers, L., Das, A., Looper, J., Mahalingam, R., Nagel, M.A.: Elevated serum substance P during simian varicella virus infection in rhesus macaques; implications for chronic inflammation and adverse cerebrovascular events. J. NeuroVirol. 26:945-951, 2020.

118.   Johnson, R.J., Gomez-Pinilla, F., Nagel, M., Nakagawa, T., Rodriguez-Iturbe, B., Sanchez-Lozada, L.G., Tolan, D.R., Lanaspa, M.A.: Cerebral fructose metabolism as a potential mechanism driving Alzheimer’s disease. Front. Aging Neurosci. 12:560865, 2020.

117.   Baxter, B.D., Larson, E.D., Feinstein, P., Polese, A.G., Bubak, A.N., Niemeyer, C.S., Hassell Jr., J., Merle, L., Shepherd, D., Ramakrishnan, V.R., Nagel, M.A., Restrepo, D.: Transcriptional profiling reveals TRPM5-expressing cells involved in viral infections in the olfactory epithelium. bioRxiv doi: 10.1101/2020.05.14.096016, 2020.

116. Hudish. L., Bubak, A.N., Triolo, T., Niemeyer, C.S., Sussel, L., Nagel, M.A., Taliaferro, M.J., Russ, H.A.: Modeling hypoxia induced neuropathies using a fast and scalable human motor neuron differentiation system. Stem Cell Reports 14:1033-1043, 2020.

115. Bubak, A.N., Beseler, C., Como, C.N., Tyring, S.K., Haley, C., Mescher, T., Hassell, J.E. Jr., Cohrs, R.J., Potter, H., Nagel, M.A.: Acute zoster plasma contins elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic. J. NeuroVirol. 26:422-428, 2020. 

114. Nagel, M.A., Niemeyer, C.S., Bubak, A.N.: Central nervous system infections produced by varicella zoster virus. Curr. Opin. Infect. Dis. 33:273-278, 2020.

113.   Bubak, A.N., Como, C.N., Coughlan, C.M., Johnson, N.R., Hassell, J.E. Jr., Mescher, T., Niemeyer, C.S., Mahalingam, R., Cohrs, R.J., Boyd, T.D., Potter, H., Russ, H.A., Nagel, M.A.: Varicella-zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-β, and an amyloidogenic extracellular environment. J. Infect. Dis. 221:1088-1097, 2020.

2019

112.  Traina-Dorge, V., Mehta, S., Rooney, B., Crucian, B., Doyle-Meyers, L., Das, A., Coleman, C., Nagel, M., Mahalingam, R.: Simian varicella virus DNA in saliva and buccal cells after experimental acute infection in rhesus macaques. Front. Microbiol. 10:1009, 2019.

111.  Nagel, M.A., Bubak, A.N.: (Editorial) Herpes zoster, a rash of cerebrovascular events.  Mayo Clin. Proc. 94:742-744, 2019.

110.  Blackmon, A.M., Como, C.N., Bubak, A.N., Mescher, T., Jones, D., Nagel, M.A.: Varicella zoster virus alters expression of cell adhesion proteins in human perineurial cells via interleukin 6. J. Infect. Dis. 220:1453-1461, 2019.

109. Jones, D., Como, C.N., Jing, L., Blackmon, A., Neff, C.P., Krueger, O., Bubak, A.N., Palmer, B.E., Koelle, D.M. Nagel, M.A.: Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function. PLoS Pathog. 15:e1007650, 2019.

108.   Como, C.N., Bubak, A.N., Blackmon, A.M., Jones, D., Mueller, N.H., Davidson, R., Nagel, M.A.: Varicella zoster virus induces differential cell-type specific responses in human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 60:704-711, 2019.

107.   Traina-Dorge, V., Palmer, B.E., Coleman, C., Hunter, M., Frieman, A., Gilmore, A., Altrock, K., Doyle-Meyers, L., Nagel M.A., Mahalingam, R.: Reactivation of simian varicella virus (SVV) in rhesus macaques after CD4 T cell depletion. J. Virol. 93:e01375-18, 2019.

2018

106.   Bubak, A.N., Como, C.N., Blackmon, A.M., Jones, D., Nagel, M.A.: Varicella zoster virus differentially alters morphology and suppressed proinflammatory cytokines in primary human spinal cord and hippocampal astrocytes. J. Neuroinflammation 15:318; doi: 10.1186/s12974-018-1360-9, 2018.

105.   Nagel, M.A., Bubak, A.N.: Varicella zoster virus vasculopathy. J. Infect. Dis. 218:S107-S112, 2018.

104.   Bubak, A.N., Como, C.N., Blackmon, A.M., Frietze, S., Mescher, T., Jones, D., Cohrs, R.J., Paucek, P., Baird, N.L., Nagel, M.A.: Varicella zoster virus induces nuclear translocation of the neurokinin-1 receptor, promoting lamellipodia formation and viral spread in spinal astrocytes. J. Infect. Dis. 218:1324-1335, 2018.

103.   Betker, J.L., Jones, D., Childs, C.R., Helm, K.M., Terrell, K., Nagel, M.A., Anchordoquy, T.J.: Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery. J. Control. Release 286:85-93, 2018.

102.   Mahalingam, R., Kaufer, B.B., Ouwendijk, W.J.D., Verjans, G.M.G.M., Coleman, C., Hunter, M., Das, A., Palmer, B.E., Clambey, E., Nagel, M.A., Traina-Dorge, V.: Attenuation of simian varicella virus infection by enhanced green fluorescent protein in rhesus macaques. J. Virol. 92:e02253-17, 2018.

2017

101.   Gilden, D., Nagel, M.A.: Persistent VZV ganglionitis may be the cause of postherpetic neuralgia. In: Herpes Zoster: Postherpetic Neuralgia and Other Complications (C.P.N. Watson, A.A. Gerson, M.N. Oxman, eds.), Springer International Publishing, Switzerland, Chap. 14:189-195, 2017.

100.   Nagel, M.A., Gilden, D.: The role of varicella zoster virus in giant cell arteritis. In: Herpes Zoster: Postherpetic Neuralgia and Other Complications (C.P.N. Watson, A.A. Gerson, M.N. Oxman, eds.), Springer International Publishing, Switzerland, Chap. 7:77-84, 2017.

99.  Jones, D., Neff, C.P., Palmer, B.E., Stenmark, K., Nagel, M.A.: Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment. Neurol. Neuroimmunol. Neuroinflamm. 4:e382; doi: 10.1212/NXI.0000000000000382, 2017.

98.  Nagel, M.A., Jones, D., Wyborny, A.: Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J. Neuroimmunol. 308:112-117, 2017.

97. Bert, R.J., Nagel, M.A., Friedland, R.P., Hattab, E.M., Gilden, D.H.: Varicella-zoster virus: one pathogen with multifaceted imaging and clinical manifestations influenced by varied pathophysiologic mechanisms of dissemination. Neurographics 7:20-35, 2017.

2016

96.  Gilden, D., Cohrs, R.J., Mahalingam, R., Nagel, M.A.: Varicella zoster virus infection of the nervous system. In: Neurobiology of Disease, 2nd Edition (M.V. Johnson, H.P. Adams, S.A. Fatemi, eds.), Oxford University Press, New York, Chap. 149:1075-1080, 2016.

95.  Nagel, M.A., Gilden D.: Chronic viral diseases of the CNS. In: International Neurology: A clinical Approach, 2nd Edition (R.P. Lisak, D.D. Truong, W.M. Carroll, R. Bhidayasiri, eds.), Wiley-Blackwell Publishing, Oxford, Chap. 81:323-325, 2016.

94.  Gilden, D., Nagel, M.A.: Neurological complications of human herpesvirus infections. In: International Neurology: A clinical Approach, 2nd Edition (R.P. Lisak, D.D. Truong, W.M. Carroll, R. Bhidayasiri, eds.), Wiley-Blackwell Publishing, Oxford, Chap. 81:316-322, 2016.

93.  Nagel, M.A., Burns, T.M., Gilden, D.: SUNCT headaches after ipsilateral ophthalmic-distribution zoster. J. Neurol. Sci. 366:207-208, 2016.

92. Nagel, M.A., Gilden, D.: Burning mouth syndrome associated with varicella zoster virus.  BMJ Case Rep. doi: 10.1136/bcr-2016-215953, 2016.  

91. Jones, D., Alvarez, E., Selva, S., Gilden, D., Nagel, M.A.: Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy. Neurol. Neuroimmunol. Neuroinflamm. 3:e246; doi: 10.1212/NXI.0000000000000246, 2016.

90.  Jones, D., Blackmon, A., Neff, C.P., Palmer, B.E., Gilden, D., Badani, H., Nagel, M.A.: Varicella zoster virus downregulates programmed death ligand 1 and major histocompatibility complex 1 in human brain vascular adventitial fibroblasts, perineurial cells and lung fibroblasts. J. Virol. 90:10527-10534, 2016.

89. Gilden, D., White, T., Khmeleva, N., Boyer, P.J., Nagel, M.A.: VZV in biopsy-positive and –negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol. Neuroimmunol. Neuroinflamm. 3:e216; doi: 10.1212/NXI.0000000000000216, 2016.

88. Gilden, D., White, T., Boyer, P.J., Galetta, K.M., Hedley-Whyte E.T., Frank, M., Holmes, D., Nagel M.A.: Varicella zoster virus infection in granulomatous arteritis of the aorta. J. Infect. Dis. 213:1866-1871, 2016.

87. Gilden, D., White, T., Khmeleva, N., Katz, B.J., Nagel, M.A.: Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries. J. Neurol. Sci. 364:141-143, 2016.

86.  Gilden, D., Nagel, M.A.: Varicella zoster virus triggers the immunopathology of giant cell arteritis. Curr. Opin. Rheumatol. 28:376-382, 2016.

85. Gilden, D., Grose, C., White, T., Nagae, L., Hendricks, R.L., Cohrs, R.J., Nagel, M.A.:     Successful antiviral treatment after 6 years of chronic progressive neurological disease attributed to VZV brain infection. J. Neurol. Sci. 368:240-242, 2016.

84.  Yawn, B.P., Wollan, P.C., Nagel, M.A., Gilden, D.: Risk of stroke and myocardial infarction after herpes zoster in older adults in a US community population. Mayo Clin. Proc. 91:33-44, 2016.

83. Nagel, M.A., White, T., Gilden, D.:  Varicella-zoster virus in giant cell arteritis - Reply. JAMA Neurol. 73:239, 2016

82. Nagel. M.A., Gilden. D.: Developments in varicella zoster virus vasculopathy. Curr. Neurol. Neurosci. Rep. 16:12, doi: 10:1007/s11910-015-0614-5, 2016.

81. Gilden, D., Nagel, M.A.: Varicella zoster virus and giant cell arteritis. Curr. Opin. Infect. Dis. 29:275-279, 2016.

80. Badani, H., White, T., Schulick, N., Raeburn, C.D., Topkaya, I., Gilden, D., Nagel, M.A.: Frequency of varicella zoster virus DNA in human adrenal glands. J  Neurovirol. 22:400-402, 2016.

2015

79.     Nagel, M.A.: Postherpetic neuralgia: New perspectives on pathogenesis and treatment. Pain Medicine News 13:S1-S8, 2015.

78.     Nagel, M.A., Cohrs, R.J., Mahalingam, R., Baird, N.L., Gilden, D.: Varicella zoster virus in the nervous system.  F1000Research 4 (F1000 Faculty Rev.):1356, doi: 10.12688/f1000research. 7153.1, 2015.

77.     Nagel. M.A., Choe, A., Rempel, A., Wyborny, A., Stenmark, K., Gilden, D.: Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts. J. Neurol. Sci. 358:444-446, 2015.

76.     Gilden, D., Nagel, M.A., White, T., Grose, C.: WriteClick Editor’s Choice: Is temporal arteritis due to VZV infection? Neurology 85:1914-1915, 2015.

75.     Nagel, M.A., White, T., Khmeleva, N., Rempel, A., Boyer, P.J., Bennett, J.L., Haller, A., Lear-Kaul, K., Kandasmy, B., Amato, M., Wood, E., Durairaj, V., Fogt, F., Tamhankar,, M.A., Grossniklaus, H.E., Poppiti, R.J., Bockelman, B., Keyvani, K., Pollak, L., Mendlovic, S., Fowkes, M., Eberhart, C.G., Buttmann, M., Toyka, K.V., Meyer-ter-Vehn, T., Petursdottir, V., Gilden, D.: Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol. 72:1281-1287, 2015.

 74.     Baird, N.L., Bowlin, J.L., Nagel, M.A., Gilden, D.: Varicella zoster virus. In: Antimicrobial Therapy and Vaccines, Antimicrobial Agents, 3rd Edition, (V.L. Yu, R. Weber, D. Raoult, eds.), ESun Technologies LLC, Pittsburgh, PA, 2015.

 73.     Golas, L., Bennett, J.L., White, T.M., Skarf, B., Lesser, R., Nagel, M.A., Gilden, D.: Varicella zoster virus in ischemic optic neuropathy. Ophthalmology 122:2142-2145, 2015.

72.     Gilden, D., White, T.M., Nagae, L., Gurdin, W.H., Boyer, P.J., Nagel, M.A.: Successful antiviral treatment of giant cell arteritis and Takayasu’s arteritis. JAMA Neurology. 72:943-946, 2015.

71.     Gilden, D., Nagel, M.A.: Varicella zoster virus in temporal arteries of patients with giant cell arteritis. J. Infect. Dis. 212(S1):S37-39, 2015.

70.     Gilden, D., White, T., Galetta, S.L., Fogt, F., Nagel, M.A.: Widespread arterial infection by varicella zoster virus explains refractory giant cell arteritis. Neurol. Neuroimmunol. Neuroinflamm. 2:e125; doiL:10.1212/NXI.0000000000000125, 2015.

 69.     Nagel, M.A., Choe, A., Traktinskiy, I., Gilden, D.: Burning mouth syndrome due to herpes simplex virus 1. BMJ Case Rep. doi:10.1136/bcr-2015-209488, 2015.

68.     Nagel, M.A., Lenggenhager, D., White, T., Khmeleva, N., Heintzman, A., Boyer, P.J., Gilden. D.:  Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J. Clin. Virol. 66:72-75, 2015.

67.     Gilden, D., White, T., Khmeleva, N., Heintzman, A., Choe, A., Boyer, P.J., Grose, C., Carpenter, J.E., Rempel, A., Bos, N., Kandasamy, B., Lear-Kaul, K., Holmes, D.B., Bennett, J.L., Cohrs, R.J., Mahalingam, R., Mandava, N., Eberhart, C.G., Bockelman, B., Poppiti, R.J., Tamhankar, M.A., Fogt, F., Amato, M., Wood, E., Durairaj, V., Rasmussen, S., Petursdottir, V., Pollak, L., Mendlovic, S., Chatelain, D., Keyvani, K., Brueck, W., Nagel, M.A.: Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84:1948-1955, 2015.

66.     Nagel, M.A., Gilden, D.: The relationship between herpes zoster and stroke. Curr. Neurol. Neurosci. Rep. 15:16, doi: 10.1007/s11910-015-0534-4, 2015.

2014

65.     Nagel, M.A., Gilden, D.:  Stroke caused by varicella zoster virus. UpToDate: www.uptodate.com, version 9, 2014.

 64.     Nagel, M.A., James, S.F., Traktinskiy, I., Wyborny, A., Choe, A., Rempel, A., Baird, N.L., Gilden, D.: Inhibition of pSTAT1 nuclear accumulation and antiviral Mx1 expression in human brain vascular adventitial fibroblasts infected with varicella zoster virus. J. Virol. 88:11634-11637, 2014.

63.     Nandhagopal, R., Khmeleva, N., Jayakrishnan, B., White, T., Al Azri, F., George, J., Heintzman, A., Al Zeedy, K., Rorke-Adams, L., Gujjar, A.R., Schmid, D.S., Al-Asmi, A., Nagel, M.A., Jacob, P.C., Gilden, D.:  VZV pneumonitis and brainstem encephalitis without skin rash in an immunocompetent adult. Open Forum Infect. Dis. (Summer) 1: doi:10.1093/ofid/ofu064, 2014.

62.     Gilden, D., Nagel, M.A., Cohrs, R.J.: Varicella zoster. In: Neurovirology, Handbook of Clinical Neurology, 3rd Series (A. Tselis, J. Booss, eds.), Elsevier Publishing Services, India, Vol. 123, Chap. 12:265-283, 2014.

61.     Teodoro, T., Nagel, M.A., Geraldes, R., White, T., Mahalingam, R., Batista, P., Wellish, M. Pimentel, J., Khmeleva, N., Heintzman, A., Albuquerque, L., Boyer, P.J., Choe, A., Peralta, R., Gilden, D.: Biopsy-negative, VZV-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one.  J. Neurol. Sci. 343:195-197, 2014.

60.    El Kasmi, K.C., Pugliese, S.C., Riddle, S.R., Poth, J.M., Anderson, A.L., Frid, M.G., Li, M., Pullamsetti, S.S., Savai, R., Nagel, M.A., Fini, M.A., Graham B.B., Tuder, R.M., Friedman, J.E., Eltzschig, H.K., Sokol, R.J., Stenmark, K.R.: Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension. J. Immunol. 193:597-609, 2014.

59.     Nagel, M.A., Rempel, A., Huntington, J., Kim, F., Choe, A., Gilden, D.: Frequency and abundance of α-herpesvirus DNA in human thoracic sympathetic ganglia. J. Virol. 88:8189-8192, 2014.

58.     Liberman, A., Nagel, M.A., Hurley, M.C., Caprio, F.Z., Bernstein, R.A., Gilden, D.: Rapid development of nine cerebral aneurysms in VZV vasculopathy. Neurology 82:2139-2141, 2014.

57.     Birlea, M., Nagel, M.A., Cohrs, R.J., Mahalingam, R., James, S., Gilden, D.: VZV. In: Encyclopedia of Neurological Sciences (M.J. Aminoff, R.D. Daroff, eds.), Oxford, Academic Press, Vol. 4, pp. 602-608, 2014.

56.     Nagel, M.A., Gilden, D.: Neurological complications of VZV reactivation. Curr. Opin. Neurol. 27:356-360, 2014.

55.     Nagel, M.A., Gilden, D.: Update on varicella zoster virus vasculopathy. Curr. Infect. Dis. Rep. 407:1-8, 2014.

54.     Nagel, M.A., Gilden, D.: Varicella zoster virus infection: Generally benign in kids, bad in grown-ups. Clin. Infect. Dis. 58:1504-1506, 2014.

53.     Sabry, A., Hauk, P.J., Jing, H., Su, H.C., Stence, N.V., Mirsky, D.M., Nagel, M.A., Abbott, J.K., Dragone, L.L., Armstrong-Wells, J., Curtis, D.J., Cohrs, R., Schmid, D.S., Gilden, D., Gelfand, E.W.: Vaccine strain varicella zoster virus-induced CNS vasculopathy as the presenting feature of DOCK8 deficiency. J. Allergy Clin. Immunol. 133:1225-1227, 2014.

52.     Nagel, M.A., Khmeleva, N., Choe, A., Gutierrez, J., Gilden, D.: Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation. J. Neurol. Sci. 339:32-34, 2014.

51.     Birlea, M., Nagel, M.A., Khmeleva, N., Choe, A., Kleinschmidt-DeMasters, B., Hevner, R., Boyer, P., Lear-Kaul, K.C., Bos, N., Wellish, M., Cohrs, R.J., Gilden, D.: VZV trigeminal ganglioneuritis without rash. Neurology 82:90-92, 2014.

50.    Nagel, M.A.: Varicella zoster virus vasculopathy: clinical features and pathogenesis. J. Neurovirol. 20:157-163. 2014.

2013

49.     Nagel, M.A., Khmeleva, N., Boyer, P.J., Choe, A., Bert, R., Gilden, D.: VZV in the temporal artery of a patient with GCA. J. Neurol. Sci. 335:228-230, 2013.

48.     Nagel, M.A., Gilden, D.: Complications of VZV reactivation. In: Current Treatment Options in Neurology (A. Pruitt, ed.), Springer, New York, Chap. 15:439-453, 2013.

47.     Gilden, D., Nagel, M.A., Cohrs, R.J., Mahalingam, R.: The variegate neurological manifestations of VZV infection. Curr. Neurol. Neurosci.Rep. 13:374, doi: 10.1007/s11910-013-0374-2z, 2013.

46.     Nagel, M.A., Choe, A., Gilden, D., Traina-Dorge, V., Cohrs, R.J., Mahalingam, R.: GeXPS multiplex PCR analysis of the simian varicella virus transcriptome in productively infected cells in culture and acutely infected ganglia. J. Virol. Methods 193:151-158, 2013.

45.     Nagel, M.A., Bennett, J.L., Khmeleva, N., Choe, A., Rempel, A., Boyer, P.J., Gilden, D.: Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology 80:2017-2021, 2013.

44.     Tsai, J., Nagel, M.A., Gilden, D.: Skin rash in meningitis and meningoencephalitis. Neurology 80:1808-1811, 2013.

43.     Nagel, M.A., Choe, A., Khmeleva, N., Overton, L., Rempel, A., Wyborny, A., Traktinskiy, I., Gilden, D.: Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries. J. NeuroVirol. 19:181-185, 2013.

42.     Nagel, M.A., Gilden, D.: The challenging patient with VZV disease. Neurol. Clin. Pract. 3:109-117, 2013.

41.     Mathias, M., Nagel, M.A., Khmeleva, N., Boyer, P.J., Choe, A., Durairaj, V.D., Bennett, J.L., Mandava, N., Gilden, D.: VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J. Neurol. Sci. 325:180-182, 2013.

40.     Nagel, M.A., Russman, A.N., Feit, H., Traktinskiy, I., Khmeleva, N., Schmid, D.S., Skarf, B., Gilden, D.: VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology 80:220-222, 2013.

39.     Nagel, M.A., Traktinskiy, I., Stenmark, K.R., Frid, M.G., Choe, A., Gilden, D.: VZV vasculopathy: immune characteristics of virus-infected arteries. Neurology 80:62-68, 2013.

38.     Nagel, M.A., Cohrs, R.J., Gilden, D.: Varicella zoster virus infections. In: Viral Infections of the Human Nervous System (A.C. Jackson, ed.), Springer Basel, London, pp. 87-114, 2013.

2012

37.     Silver, B., Nagel, M.A., Mahalingam, R., Cohrs, R., Schmid, D.S., Gilden, D.: Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration. J. Neurol. Sci. 323:245-247, 2012.

36.     Nagel, M.A., Bert, R.J., Gilden, D.: Raeder syndrome produced by extension of chronic inflammation to the internal carotid artery. Neurology 79:1296-1299, 2012.

35.     Ouwendijk, W.J.D., Choe, A., Nagel, M.A., Gilden, D., Osterhaus, A.D.M.E., Cohrs, R.J., Verjans, G.M.G.M.: Restricted varicella zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 86:10203-10206, 2012.

34.     Wolf, J., Nagel, M.A., Mahalingam, R., Cohrs, R.J., Schmid, D.S., Gilden, D.: Chronic active varicella zoster virus infection. Neurology 79:828-829, 2012.

33.     Tsai, J., Cohrs, R.J., Nagel, M.A., Mahalingam, R., Schmid, D.S., Choe, A., Gilden, D.:  Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness. J. Neurol. Sci. 313:193-195, 2012.

32.     Nagel, M.A., Traktinskiy, I., Choe, A., Rempel, A., Gilden, D.: Varicella-zoster virus expression in the cerebral arteries of diabetic subjects. Arch. Neurol. 69:142-144, 2012.

2011

31.     Nagel, M.A., Gilden, D.: The trigeminal trophic syndrome. Neurology 77:1499, 2011.

30.     Nagel, M.A., Choe, A., Cohrs, R.J., Traktinskiy, I., Sorensen, K., Mehta, S.K., Pierson, D.L., Tyring, S.K., Haitz, K., DiGiorgio, C., LaPolla, W., Gilden, D.: Persistence of VZV DNA in saliva after herpes zoster. J. Infect. Dis. 204:820-824, 2011.

29.     Nagel, M.A., Traktinskiy, I., Azarkh, Y., Kleinschmidt-DeMasters, B., Hedley-Whyte, T., Russman, A., VanEgmond, E.M., Stenmark, K., Frid, M., Mahalingam, R., Wellish, M., Choe, A., Cordery-Cotter, R., Cohrs, R.J., Gilden, D.: Varicella zoster virus vasculopathy: Analysis of virus-infected arteries. Neurology 77:364-370, 2011.

28.     Gilden, D., Mahalingam, R., Nagel, M.A., Pugazhenthi, S., Cohrs, R.J.: The neurobiology of varicella zoster virus infection. Neuropathol. Appl. Neurobiol. 37:441-463, 2011.

27.     Pugazhenthi, S., Nair, S., Velmurugan, K., Liang, Q., Mahalingam, R., Cohrs, R.J., Nagel, M.A., Gilden, D.: VZV infection of differentiated human neural stem cells. J. Virol. 85:6678-6686, 2011.

26.     Azarkh, Y., Dölken, L., Nagel, M., Gilden, D., Cohrs, R.J.: Synthesis and decay of varicella zoster virus transcripts. J. NeuroVirol. 17:281-287, 2011.

25.     Pierson, D.L., Mehta, S.K., Gilden, D., Cohrs, R.J., Nagel, M.A., Schmid, D.S., Tyring, S.K.: Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J. Infect. Dis. 203:1542-1545, 2011.

24.     Salazar, R., Russman, A.N., Nagel, M.A., Cohrs, R.J., Mahalingam, R., Schmid, D.S., Kleinschmidt-DeMasters, B.K., VanEgmond, E.M., Gilden, D.: VZV ischemic optic neuropathy and subclinical temporal artery involvement. Arch. Neurol. 68:517-520, 2011.

23.     Nagel, M.A., Choe, A., Traktinskiy, I., Cordery-Cotter, R., Gilden, D., Cohrs, R.J.: Varicella zoster virus transcriptome in latently infected human ganglia. J. Virol. 85:2276-2287, 2011.

22.     Blumenthal, D.T., Shacham-Shmueli, E., Bokstein, F., Schmid, D.S., Cohrs, R.J., Nagel, M.A., Mahalingam, R., Gilden, D.: Zoster sine herpete: virological verification by detection of anti-VZV IgG antibody in CSF. Neurology 76:484-485, 2011.

2010

21.     Nagel, M.A., Gilden, D., Mahalingam, R., Cohrs, R.J.: Neurologic manifestations of herpes zoster. In: Neuroinflammation Insights Series (A. Minagar, ed.), Elsevier, Chap. 23:497-520, 2010.

20.     Gilden, D., Cohrs, R.J., Mahalingam, R., Nagel, M.A.: Neurological disease produced by VZV reactivation without rash. Curr. Top. Microbiol. Immunol. 342:243-253, 2010.

19.     Nagel, M.A., Gilden, D.: Stroke caused by varicella zoster virus. UpToDate: www.uptodate.com, version 8, May 2010.

18.     Nagel, M.A., Mahalingam, R., Cohrs, R.J., Gilden, D.: Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect. Disord. Drug Targets 10:105-111, 2010.

2009

17.     Umbach, J.L., Nagel, M.A., Cohrs, R.J., Gilden, D.H., Cullen, B.R.: Analysis of human a-herpesvirus microRNA expression in latently infected human trigeminal ganglia. J. Virol. 83:10677-10683, 2009.

16.     Gilden, D., Cohrs, R.J., Mahalingam, R., Nagel, M.A.: VZV vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis and treatment. Lancet Neurol. 8:731-740, 2009.

15.     Nagel, M.A., Gilden, D., Shade, T., Gao, B., Cohrs, R.J.: Rapid and sensitive detection of 68 unique VZV gene transcripts in five multiplex reverse transcription-polymerase chain reactions. J. Virol. Methods 157:62-68, 2009.

14.     Gilden, D., Nagel, M.A., Mahalingam, R., Mueller, N.H., Brazeau, E.A., Pugazhenthi, S., Cohrs, R.J.: Clinical and molecular aspects of VZV infection. Future Neurol. 4:103-117, 2009.

13.     Gilden, D., Nagel, M.A., Ransohoff, R.M., Cohrs, R.J., Mahalingam, R., Tanabe, J.L.: Recurrent varicella zoster virus myelopathy. J. Neurol. Sci. 276:196-198, 2009.

2008

12.     Mueller, N.H., Gilden, D.H., Cohrs, R.J., Mahalingam, R., Nagel, M.A.: VZV infection: clinical features, molecular pathogenesis of disease and latency. Neurol. Clin. 26:675-697, 2008.

11.     Nagel, M.A., Cohrs, R.J., Mahalingam, R., Wellish, M.C., Forghani, F., Schiller, A., Safdieh, J.E., Kamenkovich, E., Ostrow, L.W., Levy, M., Greenberg, B., Russman, A.N., Katzan, I., Gardner, C.J., Häusler, M., Nau, R., Saraya, T., Wada, H., Goto, H., de Martino, M., Ueno, M., Brown, W.D., Terborg, C., Gilden, D.H.: The varicella zoster virus vasculopathies: clinical, CSF, imaging and virological features. Neurology 70:853-860, 2008.

10.     Nagel, M.A., Corboy, J.R.: Viral illnesses of the nervous system of the elderly. In: Clinical Neurology of the Older Adult (J.I. Sirven, B.L. Malamut, eds.), Lippincott Williams & Wilkins, Philadelphia, pp. 448-456, 2008.

2007

9.       Orme, H.T., Smith, G., Nagel, M.A., Bert, R.J., Mickelson, T.S., Gilden, D.H.: VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology 69:398-400, 2007.

8.       Nagel, M.A., Gilden, D.H.: The protean neurologic manifestations of varicella zoster virus infection. Cleve. Clin. J. Med. 74:489-504, 2007.

7.       Nagel, M.A., Forghani, B., Mahalingam, R., Wellish, M.C., Cohrs, R.J., Russman, A.N., Katzan, I., Lin, R., Gardner, C.J., Gilden, D.H.: The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069-1073, 2007.

2006

6.       Moses, H., Nagel, M.A., Gilden, D.H.: Acute cerebellar ataxia in a 41-year-old woman. Lancet Neurol. 5:984-988, 2006.

2003

5.       Dodson, R.E., Goolsby, K.M., Acena-Nagel, M., Mao, C., Shapiro, D.J.: RNA gel shift assays for analysis of hormone control of mRNA stability. Methods Enzymol. 364:350-361, 2003.

2000

4.       Cunningham, K.S., Dodson, R.E., Nagel, M.A., Shapiro, D.J., Schoenberg, D.R.: Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1. Proc. Natl. Acad. Sci. U.S.A. 97:12498-12502, 2000.

1995

3.       Dodson, R.E., Acena, M.R., Shapiro, D.J.: Tissue distribution, hormone regulation and evidence for a human homologue of the estrogen-inducible Xenopus laevis vitellogenin mRNA binding protein. J. Steroid Biochem. Mol. Biol. 52:505-515, 1995.

1993

2.       Koeppen, H., Acena, M., Drolet, A., Rowley, D.A., Schreiber, H.: Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes. Eur. J. Immunol. 23:2770-2776, 1993.

1992

1.       Singh, S., Ross, S.R., Acena, M., Rowley, D.A., Schreiber, H.: Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J. Exp. Med. 175:139-146, 1992.